Skip to content

Study of an Implantable Collamer Lens (ICL)

Proof of Concept Study of an Aspheric Optic Phakic Implantable Collamer Lens (ICL)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07791381
Enrollment
10
Registered
2026-08-27
Start date
2026-11-01
Completion date
2027-05-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

A prospective, open-labeled, single-site study of an implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Interventions

ICL with aspheric optic

Sponsors

Staar Surgical Company
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Must be between the age of 21 - 60 years, * Must be suitable for ICL surgery, * Must meet all unique study eligibility criteria

Exclusion criteria

* Outside the age of 21 - 60 years, * Not a suitable candidate for ICL surgery, * Does not meet all unique study eligibility criteria

Design outcomes

Primary

MeasureTime frameDescription
Cumulative and Persistent Adverse Events3 MonthsSafety Population

Contacts

CONTACTJennifer Director, Clinical Operations
jlynch@staar.com585-749-7910
CONTACTLaura Schall
lschall@staar.com
PRINCIPAL_INVESTIGATORGabriel Quesada Larez, MD

Clinica Quesada SA de CV

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026